Impact of Ambulatory Care Pharmacist-Led Management on Hemoglobin A1c Values among Patients with Uncontrolled Diabetes in a Primary Care Clinic vs Usual Care over Two Years

Background: Literature has shown the positive impact of ambulatory care pharmacists on diabetes management, yet additional research clinical outcomes compared to traditional models is warranted. Objective: The objective this study evaluate an pharmacist glycemic control over two years patients who received usual care. Methods: This retrospective cohort matched with a baseline hemoglobin A1c (HgbA1c) ≥8% managed by primary outcome was mean change in HgbA1c years. secondary were difference (1) proportion achieving <8%, (2) blood pressure <130/80 mmHg, (3) LDL, (4) prescribed SGLT2 inhibitors, GLP-1RA, and sulfonylureas, (5) severe hypoglycemia after Results: Data for 180 analyzed 10% at vs 8.2% (adjusted -1.92) among pharmacist-managed patients, 9.9% 9% respectively -0.98) (p=0.004). Among 53.5% achieved <8% 34.2% (p=0.014). There no statistically significant differences goal pressure, or between groups. After years, 18.3% 5.8% inhibitor (p=0.008), 46.7% 9.2% GLP-1RA (p<0.001). No found sulfonylurea utilization. Conclusion: Patients >8% had twice reduction significantly more utilization inhibitors as controls provided